In conclusion, it elucidated the critical role of cytosolic mtDNA-induced cGAS-STING activation in the pathogenesis of obesity-related DCM and provided preclinical validation as a new potential therapeutic strategy for the treatment of DCM. The gene discussed is STING1; the disease is obesity due to melanocortin 4 receptor deficiency.